在荷兰北部和德国边境地区,全科医生的抗生素处方决定:一个离散选择实验
Vaitiare Mulderij-Jansen1, Michael Bui2, Janine van Til2
1Department of Medical Microbiology and Infection Prevention, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. v.i.c.jansen@umcg.nl.
BMC primary care
|December 3, 2025
概括
临床因素,如C反应性蛋白 (CRP) 水平,并发症和发烧显著影响全科医生对上呼吸道感染 (URTI) 开处方的抗生素. 患者压力和时间限制等非临床因素的影响最小.
科学领域:
- 一般的做法一般的做法
- 传染性疾病 传染性疾病
- 医疗保健服务研究 医疗服务研究
背景情况:
- 抗生素 (ABX) 耐药性的上升需要了解处方行为.
- 德国和荷兰之间存在ABX处方率的差异,特别是在边境附近.
- 一般医生 (GPs) 是主要的处方者,特别是在上呼吸道感染 (URTI) 方面.
研究的目的:
- 评估主观和客观决定因素如何影响全科医生对URTI的ABX处方决定.
- 量化临床和非临床因素对ABX处方的影响.
- 以量化数据扩展之前的定性发现.
主要方法:
- 使用离散选择实验 (DCE) 来分析ABX处方决策.
- 一般医生根据CRP水平,并发症,发烧,时间限制,患者压力和语言能力等属性评估虚构的患者场景.
- 使用条件逻辑模型来分析选择和赋值重要性.
主要成果:
- 较高的CRP水平 (40 mg/L与10 mg/L相比) 显著增加了预期的ABX处方 (或6.13).
- 伴随性疾病 (II型糖尿病) (OR 2.78) 和发烧 (OR 2.07) 的存在也显著增加了处方的可能性.
- 慢性脊髓炎 (47%),并发病率 (26%),临床表现 (19%) 是最重要的因素;非临床因素的重要性为<5%.
结论:
- 临床因素,特别是像CRP这样的客观措施,是预期ABX为URTI处方的主要驱动因素.
- 非临床因素在全科医生关于URTI抗生素使用的决定中起到很小的作用.
- 研究结果强调了临床指标在指导适当的抗生素管理中的重要性.
更多相关视频
相关概念视频
00:57Antibiotic Selection
Overview
01:16Crossover Experiments
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
01:22Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
01:15Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
01:21Microbiota Modulation by Antibiotics
Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...